Heart of Boston Leadership

Building on a century of lifesaving progress in cardiovascular disease and stroke, the American Heart Association has centered a new vision for its next 100 years: Advancing health and hope for everyone, everywhere.

To achieve this vision by 2028, the American Heart Association will drive breakthroughs and implement proven solutions in science, policy and care for healthier people and communities. The greatest discoveries in health must reach people where they are.

Every person means working with every community and that is why our Executive Leadership is so important. The Heart of Boston Campaign is a catalyst for this work.

2026 Heart of Boston Chairperson

Christine Lindenboom
Chief Corporate Communications Officer
Alnylam Pharmaceuticals

Executive Leadership Team

Dr. Sameer Bansilal
Global Head – TTR Medical Affairs
Alnylam Pharmaceuticals

Michael Dandorph
CEO
Tufts Medicine

Rena Denoncourt
COO
Corsera Health

Nicholas Downing
Partner
Bain Capital Life Sciences

Simon Fox
Vice President Development Programs
Alnylam Pharmaceuticals

Barry Greene
Pharmaceutical Consultant & CEO
Sage Therapeutics

Eric Green
Chief Operating Officer
Seaport Therapeutics

Peter Lawrence
CEO
Cardurion Pharmaceuticals

Lorraine Rusch
CEO & President
Cardiovascular Clinical Sciences

Carol Ann Satler
VP Clinical Development
Insilico Medicine

Dr. Stanley Shaw
Associate VP Global Medical, CVD Area Lead
Amgen